Prostate is a multicenter registry focused on monitoring patients with metastatic prostate cancer and their treatment modalities.
start of the project: 12/2024
Primary Objective:
Mapping the epidemiological and clinical data of patients with advanced and metastatic prostate cancer in the Czech Republic and Europe.
Monitoring the long-term course of the disease and the effectiveness of individual treatment approaches.
Secondary Objectives:
Analyze different types of treatment, including radiotherapy, surgical procedures, and systemic therapies, to evaluate their benefits and risks.
Monitor treatment side effects and key laboratory parameters that influence treatment outcomes.
Evaluate treatment sequences, time to disease progression, and overall patient survival.
Expert Guarantee
Masaryk Memorial Cancer Institute, Brno
The registry is supervised by Assoc. Prof. Alexandr Poprach, MD, Ph.D.
Project Management
Institute of Biostatistics and Analyses, Ltd., a spin-off company of Masaryk University, ensures management and other service activities for this project.
Mgr. Eva Adamová, Ph.D., Project Manager
Ing. Petr Brabec, Ph.D., Managing Director
- Anaesthesiology, intensive care medicine
- Cardiology, angiology
- Diabetology, dietetics
- Educational projects
- Emergency medicine, toxicology
- Endocrinology, metabolism
- Gastroenterology, hepatology
- Haematology, haematological oncology
- Immunology, allergology
- Medical genetics
- Nephrology
- Neurology, neurosurgery
- Nursing care
- Obstetrics, gynaecology
- Oncology, radiotherapy
- Ophthalmology
- Paediatrics, neonatology
- Pathology, laboratory medicine
- Pulmonary medicine
- Rheumatology, physiotherapy
- Screening programmes
- Surgery, traumatology, orthopaedics
- Urology